P24, P30, and P39, the three major surface antigens of the envelope of hepatitis B virus, are co-carboxyterminal proteins with different amino-terminal extensions. We prompted expression of these proteins in Chinese hamster ovary (CHO) cells by placing the appropriate coding sequence(s) under the control of the simian virus 40 early promoter. P24 and P30 formed 22-nm particles which were efficiently secreted. In contrast, P39 accumulated in a perinuclear structure, presumably the Golgi complex, and was not secreted. Coexpressing P39 and P24 resulted in the localization of both in the perinuclear region and restricted the secretion of P24. We found that P39 must be expressed at a relatively low level to allow efficient secretion of P24 in typical spherical particles. We hypothesize that P39, by inhibiting the formation of spherical particles, helps to induce formation of filamentous particles and mature Hepatitis B virus.
Hepatitis B virus (HBV) causes acute and chronic hepatitis in humans and is causally linked to the most prevalent cancer in the world, hepatocellular carcinoma (3). The 42-nm HBV particle is an enveloped virus (22) ; this envelope constitutes two other HBV-related spherical and filamentous 22-nm particles. All HBV envelope structures contain three major integral membrane proteins; these proteins, termed surface antigens (HBsAg), are designated P24 (S protein), P30 (preS-2 protein), and P39 (preS-1 protein), reflecting their molecular weights (8, 22) . P24 is the major envelope HBsAg. P30 comprises the entire sequence of P24 with an additional 55 amino acids at the amino terminus (pre-S2 region). P24 and P30 have been successfully expressed in heterologous systems for the production of vaccine (12, 13, 16, 19, 24) . P39 contains the entire sequence of P30 and an additional 117 amino acids at the amino terminus (the pre-1S region) (25) . Thus, these three different HBsAgs are cocarboxy-terminal proteins with different amino-terminal extensions. The function of P39 is unknown. Heermann et al. (8) have shown that P39 represents 10 to 20% of the HBsAg proteins on the 22-nm filamentous particles, but only 1 to 2% of the HBsAg in the spherical particles. It seemed conceivable that P39 plays a role in the morphogenesis of HBV particles. For this paper we studied the functions of P39 through the selective expression of (14) . A cell line expressing P39 obtained by G418 selection was treated with increasing concentrations of methotrexate up to 2 F.M by a previously described method (2) . This treatment increases the expression level of P39 fivefold. CHO-8 and CHO-0.6 cell clones were established by cotransfecting cells with both P24 and P39 sequences at a molecular ratio of 5 to 1.
Primer extension experiments. Primer extension experiments were carried out with a synthetic 39-mer comprising nucleotides 123 to 161 of the antisense strand of the HBV genome (25) . The details of the experiments are as follows. A 10-p.g amount of total cellular RNA (8 ,ug of CHO-P39 RNA) was incubated with 2 x 106 cpm end-labeled primers in 6 0.5% Nonidet P-40 and 1 mM phenylmethylsulfonyl fluoride. The nuclei were sedimented in a microfuge, and sodium dodecyl sulfate was added (1% final concentration) to the supernatant (about 1 ml). The surface antigens were precipitated from a 200-pdl aliquot with a monoclonal antibody against HBsAg (a generous gift of George Kuo, Chiron Corporation).
Immunochemistry. The procedures for cytoplasmic staining have been described previously (14) . For cell surface staining, the cells on cover slips were chilled on ice and washed twice with 4°C Ham F-12 medium containing 10% fetal bovine serum and 0.05% NaN3. The primary antibody (guinea pig anti-HBsAg, 1:100 dilution) was incubated with the cells on the cover slip for 45 min at 4°C. After The results of immunoprecipitation of the HBsAg proteins expressed in CHO cells are shown in Fig. 2 . Lanes 1 to 6 display the intracellular HBsAg proteins; lanes 7 to 10 show the proteins precipitated from the medium. P39, P30, and P24 protein bands were identified by running in parallel a sample containing in-vitro-translated P39, P30, and P24 (data not shown). Two major HBsAg proteins were precipitated from the cellular extract of CHO-P39 cells (lane 2). The lower-molecular-weight species (arrowhead) comigrated with in-vitro-translated P39 and thus probably represent P39. The higher-molecular-weight species is presumably the glycosylated form of P39 (GP42) reported by Heermann et al. (8) . CHO-P24 (lane 4) produced two major HBsAg proteins. The lower-molecular-weight protein comigrated with P24 translated in vitro and therefore presumably represents P24 produced in vivo. The higher-molecular-weight protein has the characteristics of glycosylated P24 (gp27) reported by other groups (8, 17) . CHO-P30 produced four major species of HBsAg (lane 3). The two higher-molecularweight proteins migrated slightly more slowly than did P30 and therefore presumably represent the two different glycosylated forms of P30, viz., gp33 and gp36 (8) . The lower-molecular-weight proteins comigrated with P24 and GP27. Since the expression of the P30 sequence in cells was controlled by the SV40 early promoter, which directs only the transcription of P30 mRNA (Fig. 1, lane 4 (8, 17) are expressed in various cell clones. In agreement with the results shown in Table 1 , P24 and P30 proteins were produced and secreted from CHO-P24 and CHO-P30 cells (lanes 9 and 10), whereas P39 was produced intracellularly but was not secreted (lanes 2 and 8) . Electron microscopy with negative staining confirmed that, as previously reported (10, 12, 16, 17, 19, 24) , both CHO-P24 and CHO-P30 cells produce 22-nm particles (data not shown).
Cellular localization of various HBsAgs expressed. The various HBsAg proteins were localized within the cells by immunofluorescence as described in Materials and Methods. The results are shown in Fig. 3 . Cytoplasmic staining of HBsAgs was more intense in CHO-P24 and CHO-P30 cells than in control CHO cells (Fig. 3A through C) . Furthermore, the staining was associated with fibrous structures, presumably the endoplasmic reticulum (ER). This observation is consistent with the results of studies suggesting that HBsAgs are membrane proteins which form 22-nm particles by a budding process occurring in the ER (6, 9, 26) . In contrast, in CHO-P39 cells, most of the HBsAg staining was associated with the perinuclear region in Golgi-like structures rather than in the ER (Fig. 3D) . CHO-8 and CHO-0.6 cells (Fig. 3E and F, respectively) displayed HBsAg staining which was somewhat different from that of CHO-P24, CHO-P30, or CHO-P39 cells. In both CHO-8.0 and CHO-0.6 cells, intense labeling was seen in the perinuclear region, and less was seen in fibrous structures. Furthermore, the insoluble globular structures (Fig. 3F ) related to the staining pattern were evident by phase-contrast microscopy (data not shown). P39 thus apparently restricted the localization of HBsAgs to these cellular structures; this may explain the inhibition by P39 of the secretion of HBsAg particles.
Analysis of HBsAgs present on the cell surface of CHO cell transformants. Immunofluorescence studies showed that there are very few HBsAg molecules on the cell surface of any of the CHO cells expressing HBsAg. The lack of detectable cell surface immunofluorescence for CHO-P39 cells is illustrated in Fig. 3G and H; similar results were found with CHO-P24 and CHO-P30 cells (data not shown). FACS experiments were also carried out, as illustrated in 
DISCUSSION
We have shown in this paper that in contrast to P24 and P30, which form 22-nin-particles and are efficiently secreted, P39 accumulates at the Golgi complex and is not secreted. P39 also causes P24 to accumulate in the Golgi complex and inhibits secretion of HBsAg particles. Our finding that P24 and P30 are associated with ER is consistent with the previous report that transport of HBsAg through the ER may be rate limiting in the secretion process (17) . This hypothesis was based on the observation that the glycosylated form of intracellular P24 contains high mannose oligosaccharide chains and that of the secreted P24 contains complex oligosaccharide chains (17) . The P39-imposed restriction on the transport of HBsAg through the ER may be due to the association of these molecules with P39 via intermolecular (S-S?) linkages in the Golgi complex. This in turn could restrict transport and secretion of HBsAg 22-nm spherical particles and may thus favor the formation of the more complicated structures, i.e., the 22-nm filamentous forms and the virus itself. This is consistent with the preferential localization of P39 in filamentous particles and mature HBV (8) . In the context of its putative role, it is significant that the expression of P39 is controlled by a separate promoter from that of P24 and P30 (4, 15, 18, 20) ; thus its expression can be independently regulated. This could result in phasing the formation of the different viral structures during the virus life cycle. We have, however, been unable to find filamentous particles in the medium of either CHO-8 or CHO-0.6 cells by electron microscopy. This contrasts with the Alexander hepatoma cell line (PLC/PRF/5) (1), in which filamentous particles can be observed (data not shown), even though P39 mRNA represents only 2% of the HBsAg mRNA (15 
